EC Neurology

Short Communication Volume 16 Issue 8 - 2024

Multifactorial Management of Epilepsy. An Perentory Need

Juan Enrique Bender del Busto*

Philosopher Doctor, Second Degree Specialist in Neurology, Full Professor and Researcher, International Center of Neurological Restoration (CIREN), Havana, Cuba

*Corresponding Author: Juan Enrique Bender del Busto, Philosopher Doctor, Second Degree Specialist in Neurology, Full Professor and Researcher, International Center of Neurological Restoration (CIREN), Havana, Cuba.
Received: February 07, 2024; Published: August 16, 2024



Epilepsy is considered by most authors to be the second largest neurological disease, affecting between 50 and 69 million people of all ages, races, social classes and regions of the world [1-4].

  1. Beghi E. “The epidemiology of epilepsy”. Neuroepidemiology2 (2020): 185-191.
  2. Valde -sGalva n RE., et al. “Epidemiologí a del descontrol de la epilepsia en un servicio de urgencias neurolo gicas”. Revue Neurologique8 (2019): 321-325.
  3. Noriega-Morales G and Shkurovich-Bialik P. “Situacio n de la epilepsia en Me xico y Ame rica Latina”. Anales Medicos (Mexico)3 (2020): 224-232.
  4. Bender JE and Herna ndez L“Some. aspects to consider in epilepsy mortality”. CPQ Neurology and Psychology5 (2019): 01-07.
  5. Bender JE. “La epilepsia, un problema de salud a escala mundial”. Revista Habanera de Ciencias Médicas5 (2018): 660-663.
  6. Epilepsia: Un imperativo de salud pu blica. Resumen. Ginebra: Organizacio n Mundial de la Salud (2019).
  7. Plan de accio n mundialintersectorial sobre la epilepsia y otros trastornos neurolo gicos 2022-2031, OMS (EB 150/Anexo 7) (2022).
  8. Guí a pra ctica del Plan de Accio n Mundial Intersectorial de la Organizacio n Mundial de Salud sobre Epilepsia y Otros Trastornos Neurolo gicos 2022- 2031, IBE (2022).
  9. Linehan C and Berg A. “Epidemiologic aspects of epilepsy”. In: Wyllie’s treatment of epilepsy principles and practice. 6th edition. Copyright © Wolters Kluwer (2015).
  10. de Aguilar-Amat MJ., et al. “Epilepsia: generalidades sobre las crisis epile pticas y la epilepsia”. Medicine - Programa de Formación Médica Continuada Acreditado72 (2023): 4205-4219.
  11. Wilmshurst JM., et al. “Epilepsy is ubiquitous, ¿but more devastating in the poorer regions of the . . or is it?” Epilepsia 55.9 (2014): 1322-1325.
  12. Bell GS., et al. “An unknown quantity—The worldwide prevalence of epilepsy”. Epilepsia7 (2014): 958-962.
  13. World Health Organization (WHO). Epilepsy Fact Sheet (2023).
  14. Kurisu A., et al. “Incidence and prevalence of epilepsy in Japan: a retrospective analysis of insurance claims data of 9,864,278 insured persons”. Journal of Epidemiology2 (2023): 70-75.
  15. D’Souza WJ., et al. “The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia”. Acta Neurologica Scandinavica2 (2012): 96-104.
  16. Tian N., et al. “Cause-specific mortality among children and young adults with epilepsy: Results from the U.S. national child death review case reporting system”. Epilepsy & Behavior 45 (2015): 31-34.
  17. Bender JE. “Necessary psychological and psychiatric attention in the patient with epilepsy”. EC Psychology and Psychiatry1 (2024): 01.
  18. Duble SN and Sanjeev T. “Sudden unexpected death in Epilepsy”. Indian Journal of Medical Research6 (2017): 738-745.
  19. Thurman DJ., et al. “The burden of premature mortality of epilepsy in high-income countries: a systematic review from the mortality task force of the international league against epilepsy”. Epilepsia 1 (2017): 17-26.
  20. Levira F., et al. “Premature mortality of epilepsy in low- and middle-income countries: a systematic review from the mortality task force of the international league against epilepsy”. Epilepsia1 (2017): 6-16.
  21. Jones L and Thomas R. “Sudden death in epilepsy: Insights from the last 25 years”. Seizure 44 (2017): 232-236.
  22. Robertson J., et al. “Mortality in people with intellectual disabilities and epilepsy: A systematic review”. Seizure 29 (2015): 123-133.
  23. Chen Z., et al. “Editorial: Epidemiology of epilepsy and seizures”. Frontiers in Epidemiology 3 (2023):
  24. Gaitatzis A and Sander JW. “The mortality of epilepsy revisited”. Epileptic Disorders1 (2004): 3-13.
  25. Bender JE and Santos MC. “Epidemiología de las epilepsias”. En: La atencion integral en el paciente con epilepsia. Universidad Autonoma de Ciudad Jua rez, Chihuahua, Mexico. Primera edicion (2021): 31-40.
  26. Bender JE and Gonzalez J. “Evaluacion clínica pre y postquirurgica”. En: Epilepsias farmacorresistentes. Su tratamiento en Cuba. Editorial Ciencias Medicas (2017): 9-20.
  27. Bender JE and Santos MC. “Diagnostico positivo y diferencial de un paciente con epilepsia”. En: La atencion integral en el paciente con epilepsia. Universidad Autonoma de Ciudad Jua rez, Chihuahua, Mexico. Primera edicion (2021): 41-54.
  28. Bender JE. “Algunas consideraciones en relacional metodo clínico en la epilepsia”. Revista Cubana de Neurología y Neurocirugía1 (2017): 1-5.
  29. Bender JE., et al. “Integral approach to the management of the patient with epilepsy”. Neurological Disorders and Epilepsy Journal1 (2021): 138.
  30. Bender JE and Santos MC. “Clasificacion de las crisis epilepticas”. En: La atencion integral en el paciente con epilepsia. Universidad Autonoma de Ciudad Jua rez, Chihuahua, Mexico. Primera edicion (2021): 55-71.
  31. Bender JE and Santos MC. “Etiología de las epilepsias”. En: La atencion integral en el paciente con epilepsia. Universidad Autonoma de Ciudad Jua rez, Chihuahua, Mexico. Primera edicion (2021): 73-85.
  32. Bender JE and Santos MC. “¿Que conducta terape utica debemos seguir?” En: La atencion integral en el paciente con epilepsia. Universidad Autonoma de Ciudad Jua rez, Chihuahua, Mexico. Primera edicion (2021): 87-112.

Juan Enrique Bender del Busto. “Multifactorial Management of Epilepsy. An Perentory Need”. EC Neurology  16.8 (2024): 01-05.